Smart science to improve lives™
aerial shot of wind turbine

Our strategy

Our focus on growth, innovation and sustainability aims to ensure that Croda smart science helps our customers everywhere to deliver on their consumer and sustainability commitments, while we continue creating sustainable value as a business. Our corporate strategy and our sector priorities are clearly linked to our Purpose and are enabled by our business model and powered by our people.

Our established strategy has delivered successful results even during times of global change and uncertainty. 

In 2020 we: 

  • Acquired Iberchem, a global fragrances and flavours business, strengthening our customer offer in Consumer Care 
  • Acquired Avanti Polar Lipids LLC, a US-based business creating delivery systems for pharmaceutical products, expanding our portfolio in Life Sciences
  • Invested more than GBP £120 million in manufacturing facilities including speciality excipients and leveraging Avanti expertise 
  • Increased sales despite the global pandemic, driven by second half recovery and acquisitions 

Financial performance and KPIs

View our most recent financial results and key performance indicators.

A strategy for a changing world


We continue connecting to fast-growing markets and meeting unmet customer needs to grow profit ahead of sales, ahead of volume.

We achieve this by:

  • Living and sharing our Purpose: Smart science to improve livesTM
  • Applying our strong and resilient business model 
  • Utilising our unrivalled local presence, including local, direct and digital sales
  • Creating a more balanced global manufacturing footprint
  • Proactive and targeted M&A activity: investing in high return opportunities
  • Ensuring a disciplined approach to capital allocation

Our priorities in 2021 include:

  • Continuing to build our capability in R&D, sales & marketing and digital, and our skills in Asia
  • Realising the value of a new full-service offering for Personal Care and Home Care through our Consumer Care sector
  • Continuing to scale our drug delivery business
  • Successfully integrating our acquisitions

Strategic priorities by sector

Across sectors, we are looking at more proactive M&A activity, delivering fast growth in China, scaling our biotechnology capability, building our digital capability, ensuring a robust global supply chain, and becoming an employer of choice.

Strengthen to grow Consumer Care

Already recognised as the leading market innovator, we are strengthening growth in Personal Care with the acquisition of Iberchem and unlocking the high growth potential of our Home Care business.

Expand to grow Life Sciences

With technologies aligned to global health and crop sustainability trends, we continue to build our Life Sciences brand as a high value-add solution provider to pharmaceutical and crop customers.

Refine to grow Performance Technologies

We are refining Performance Technologies to focus on high-tech markets and to reduce exposure to cyclical business.

Read more

Climate positive

Transition to a dedicated Consumer Care and Life Sciences company

Croda enters agreement to sell majority of Performance Technologies and Industrial Chemicals businesses; completing its transition into a dedicated Consumer Care and Life Sciences company

Read more
Croda's markets

Croda announces major milestone in its digital enhancement journey

Croda is today celebrating the continuation of its digital customer enhancement journey with the launch of its new corporate website,

Read more